The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat

This publication has 17 references indexed in Scilit:

• Presynaptic modulation of dopamine-induced locomotor activity by oxotremorine in nucleus accumbens of the rat
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
• The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum
  Neuropharmacology, 1982
• CHOLINERGIC ACTION IN THE NUCLEUS ACCUMBENS: MODULATION OF DOPAMINE AND ACETYLCHOLINE RELEASE
  British Journal of Pharmacology, 1982
• Effects of cholecystokinin octapeptide and its fragments on brain monoamines and plasma corticosterone
  Neurochemistry International, 1981
• Antinociceptive effect of centrally administered caerulein and cholecystokinin octapeptide (CCK-8)
  European Journal of Pharmacology, 1981
• A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing
  Neuroscience, 1980
• Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection
  European Journal of Pharmacology, 1980
• Blockade of amphetamine-induced locomotor activity and stereotypy in rats by spiroperidol but not by an atypical neuroleptic, thioridazine
  Neuropharmacology, 1980
• Serotoninergic modulation of the dopamine response from the nucleus accumbens
  Journal of Pharmacy and Pharmacology, 1976
• The actions of caerulein on the smooth muscle of the gastrointestinal tract and the gall bladder
  British Journal of Pharmacology, 1968